Julio Arronte
Obstetrics & Gynecology · Miami, FLNPI 1699793042
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 27.5% of the total. 2025 is the largest year on record at $613, 3.0 times the $205 reported in 2019.
Across 62 payments — averaging $27.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$474
- Astellas Pharma US Inc$296
- Coloplast$241
- Coopersurgical, Inc.$228
- Hologic Sales And Service, LLC$82
- Biogen$58
- plus $345 from 11 others
Across 24 payments — averaging $11,997 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$151K
- Heron Therapeutics, Inc.$120K
- Davol Inc.$17K
What the payments were for
- Food & beverage$1,723100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $474 |
| Astellas Pharma US Inc | 4 | $296 |
| Coloplast | 4 | $241 |
| Coopersurgical, Inc. | 10 | $228 |
| Hologic Sales And Service, LLC | 3 | $82 |
| Biogen | 2 | $58 |
| Channel Medsystems, Inc. | 1 | $56 |
| Evofem Biosciences, Inc. | 2 | $42 |
| Daiichi Sankyo Inc. | 2 | $41 |
| Pfizer | 2 | $39 |
| Sanofi | 2 | $37 |
| Medicem Inc. | 2 | $31 |
| Optumhealth Care Solutions, LLC | 1 | $23 |
| Myovant Sciences Inc. | 1 | $22 |
| Organon | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Mission Pharmacal Company | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,723 in reported general payments places this provider in the 65th percentile of 2,438 obstetrics & gynecology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 40 | $18,114 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $39 | $18,11440 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,438 obstetrics & gynecology providers in Florida.
Other obstetrics & gynecology in Miami
- Youssef MouhayarMiami$162K
- Rebeca MartinezMiami$108K
- Jason JamesMiami$97K
- Peter KhamvongsaMiami$67K
- Abdulrahman SinnoMiami$67K
- Ingrid ParedesMiami$65K
- Karen Salazar ValdesMiami$29K
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.